Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Aug 14, 2023. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q2 2023. Go to the latest filing (Q3 2026)

24.3B USDQ2 2023
Total value of stock positions
24.3B USD
Positions
85
Share of the ten largest
37.4%

The ten largest positions Q2 2023

  1. Visa Inc. 7.0%▲ +8.8%
  2. Danaher Corporation 4.2%new
  3. Api Group Corp 3.8%▲ +0.3%
  4. Philip Morris International 3.6%new
  5. UnitedHealth Group 3.5%▼ −14.6%
  6. GE Aerospace 3.2%▼ −17.1%
  7. Roivant Sciences Ltd 3.1%▼ −14.7%
  8. Meta Platforms 3.1%▼ −19.7%
  9. Fortive 3.0%▲ +54.4%
  10. Workday, Inc. 2.8%▲ +373.0%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q2 2023

Positions Q2 2023 per 13F filing, 16 of 16
Symbol Weight in previous quarter Shares in previous quarter Value in previous quarter Change
XYZ Block, Inc. 0.8% 2,354,123 161.6M USD sold out
Molina Healthcare Inc 0.7% 594,553 159.0M USD sold out
Equitable HLDGS Inc 0.5% 3,989,446 101.3M USD sold out
Inspire Med Sys Inc 0.4% 346,576 81.1M USD sold out
CRL Charles River Laboratories 0.4% 394,089 79.5M USD sold out
Catalent Inc 0.4% 1,201,210 78.9M USD sold out
TRV Travelers Companies (The) 0.3% 378,345 64.9M USD sold out
SNOW Snowflake 0.3% 382,757 59.1M USD sold out
Intellia Therapeutics Inc 0.3% 1,569,545 58.5M USD sold out
BSX Boston Scientific 0.3% 1,136,881 56.9M USD sold out
MRSH Marsh McLennan 0.2% 257,443 42.9M USD sold out
Option Care Health Inc 0.2% 1,090,497 34.6M USD sold out
TJX TJX Companies 0.2% 414,401 32.5M USD sold out
Talaris Therapeutics Inc < 0.1% 3,289,617 6.2M USD sold out
First Rep Bk San Francisco C < 0.1% 276,260 3.9M USD sold out
Verastem Inc < 0.1% 9,224,000 3.8M USD sold out
Plus 1 position in convertible bonds and bonds worth 86.4M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Guardant Health Inc principal 120.0M USD 86.4M USD

Breakdown by sector

  • Technology 14.8%
  • Health Care 13.0%
  • Financials 12.6%
  • Industrials 9.4%
  • Consumer Discretionary 5.4%
  • Consumer Staples 4.4%
  • Communication Services 4.2%
  • Materials 4.2%
  • Real Estate 1.5%
  • Utilities 0.4%
  • not in our coverage 30.1%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close